DONOR LEUKOCYTE INFUSIONS AS TREATMENT OF EPSTEIN-BARR-VIRUS LYMPHOPROLIFERATIVE DISORDERS (EBV-LPD) IN RECIPIENTS OF UNRELATED AND RELATED ALLOGENEIC TRANSPLANTS

被引：0
|
作者：
PAPADOPOULOS, EB [1 ]
LADANYI, M [1 ]
机构：
[1] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A214 / A214
页数：1
相关论文
共 50 条
  • [21] Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants
    Meijer, E
    Dekker, AW
    Weersink, AJL
    Rozenberg-Arska, M
    Verdonck, LF
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (03) : 596 - 607
  • [22] INFUSIONS OF DONOR LEUKOCYTES TO TREAT EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    PAPADOPOULOS, EB
    LADANYI, M
    EMANUEL, D
    MACKINNON, S
    BOULAD, F
    CARABASI, MH
    CASTROMALASPINA, H
    CHILDS, BH
    GILLIO, AP
    SMALL, TN
    YOUNG, JW
    KERNAN, NA
    OREILLY, RJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (17): : 1185 - 1191
  • [23] Epstein-Barr virus (EBV)-DNA quantification in pediatric allogeneic stem cell recipients: prediction of EBV-associated lymphoproliferative disease
    Lankester, AC
    van Tol, MJD
    Vossen, JM
    Kroes, ACM
    Claas, E
    BLOOD, 2002, 99 (07) : 2630 - 2631
  • [24] Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
    Tatfi, Moussab
    Hermine, Olivier
    Suarez, Felipe
    FRONTIERS IN IMMUNOLOGY, 2019, 9
  • [25] Systemic Epstein-Barr virus (EBV)-positive T-cell lymphoproliferative disorders (T-LPD) of childhood: a case report
    Galindo-Garcia, T. A.
    Sanchez-Sosa, S.
    Ruiz-Montanez, A.
    Zornoza-Moreno, M.
    HISTOPATHOLOGY, 2022, 81 : 151 - 151
  • [26] Posttransplant Lymphoproliferative Disorders in Epstein-Barr Virus Donor Positive/Recipient Negative Lung Transplant Recipients
    Courtwright, Andrew M.
    Burkett, Patrick
    Divo, Miguel
    Keller, Steven
    Rosas, Ivan O.
    Trindade, Anil
    Mody, Gita N.
    Singh, Steve K.
    El-Chemaly, Souheil
    Camp, Phillip C.
    Goldberg, Hilary J.
    Mallidi, Hari R.
    ANNALS OF THORACIC SURGERY, 2018, 105 (02): : 441 - 447
  • [27] EFFECTS ON IMMUNE RECONSTITUTION OF UNIRRADIATED DONOR LEUKOCYTE INFUSIONS FOR THE TREATMENT OR PROPHYLAXIS OF EBV-LYMPHOPROLIFERATIVE DISORDERS FOLLOWING UNRELATED BONE-MARROW TRANSPLANTATION (BMT)
    SMALL, TN
    PAPADOPOULOS, E
    KERNAN, NA
    OREILLY, RJ
    BLOOD, 1993, 82 (10) : A214 - A214
  • [28] Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders (LPD) and EBV-Positive Non-Hodgkin Lymphomas (NHL)
    Dalela, Disha
    Lakhotia, Rahul
    Pittaluga, Stefania
    Muppidi, Jagan
    Steinberg, Seth
    Phelan, James
    Evans, Sarah
    Pradhan, Amynah
    Jaffe, Elaine
    Wilson, Wyndham
    Roschewski, Mark
    Melani, Christopher
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S451 - S451
  • [29] Low incidence of Epstein-Barr virus-associated post-transplant lymphoproliferative disorders (EBV-PTLD) in 263 unrelated donor umbilical cord blood transplant recipients.
    Barker, JN
    Martin, PL
    Defor, T
    Weisdorf, DJ
    Kurtzberg, J
    Wagner, JE
    BLOOD, 2000, 96 (11) : 206A - 206A
  • [30] POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS (PT-LPDS) CONSISTENTLY CONTAIN TYPE-A AND NOT TYPE-B EPSTEIN-BARR-VIRUS (EBV)
    FRANK, D
    CESARMAN, E
    KNOWLES, DM
    LABORATORY INVESTIGATION, 1994, 70 (01) : A108 - A108
12345